AVCN.TO
Avicanna Inc
Price:  
0.37 
CAD
Volume:  
157,910.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AVCN.TO EV/EBITDA

0.8%
Upside

As of 2024-12-14, the EV/EBITDA ratio of Avicanna Inc (AVCN.TO) is -10.39. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AVCN.TO's latest enterprise value is 40.20 mil CAD. AVCN.TO's TTM EBITDA according to its financial statements is -3.87 mil CAD. Dividing these 2 quantities gives us the above AVCN.TO EV/EBITDA ratio.

Range Selected
Trailing P/E multiples - -
Forward P/E multiples 1.1x - 1.1x 1.1x
Fair Price 0.37 - 0.37 0.37
Upside 0.8% - 0.8% 0.8%
0.37 CAD
Stock Price
0.37 CAD
Fair Price

AVCN.TO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-12-11 -10.68
2024-12-10 -9.82
2024-12-09 -9.25
2024-12-06 -8.68
2024-12-05 -8.68
2024-12-04 -8.83
2024-12-03 -9.82
2024-12-02 -9.39
2024-11-29 -9.96
2024-11-28 -8.68
2024-11-27 -8.83
2024-11-26 -7.54
2024-11-25 -7.83
2024-11-22 -7.26
2024-11-21 -7.40
2024-11-20 -7.12
2024-11-19 -6.83
2024-11-18 -7.69
2024-11-15 -6.55
2024-11-14 -7.12
2024-11-13 -6.97
2024-11-12 -7.40
2024-11-11 -7.26
2024-11-08 -7.83
2024-11-07 -8.11
2024-11-06 -7.97
2024-11-05 -7.83
2024-11-04 -7.83
2024-11-01 -7.83
2024-10-31 -8.11
2024-10-30 -8.11
2024-10-29 -8.40
2024-10-28 -8.68
2024-10-25 -7.97
2024-10-24 -8.54
2024-10-23 -8.54
2024-10-22 -8.54
2024-10-21 -9.39
2024-10-18 -9.54
2024-10-17 -8.26
2024-10-16 -7.83
2024-10-15 -8.26
2024-10-11 -8.40
2024-10-10 -8.54
2024-10-09 -9.39
2024-10-08 -9.96
2024-10-07 -9.25
2024-10-04 -10.39
2024-10-03 -10.53
2024-10-02 -11.10